Lucid Diagnostics Inc. (LUCD) income statement
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.41+0.01 (+2.18%)
Close on Nov 18, 2026Market cap $82.86MP/E –Yield –
Lucid Diagnostics Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- -36.1%
- Operating margin
- -930.9%
- Net margin
- -959.8%
- Return on equity, FY2025
- -710.6%
Financial strength
- Current ratio
- 1.33
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 121.4%
Valuation
- P/E ratio
- –
- Price to sales
- 15.22
- Price to book
- 7.58
- Dividend yield
- –
See a number that looks wrong?